Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.
In our group, we are focused on using proteomics, mass spectrometry and biochemical approaches to understand disease processes.
The group has expertise in proteomics based methodologies and hosts a platform containing a variety of chromatography equipment and mass spectrometers.
Kessler Group Sky Garden London Nov 2018
- For Non-Scientists
- Research Overview
- Mass Spectrometry
- Public Engagement
- Photo Gallery
- Virtual tour of the Kessler Lab
- Former Group Members
The Bloom syndrome complex senses RPA-coated single-stranded DNA to restart stalled replication forks
Shorrocks A-MK. et al, (2021), Nature Communications, 12
Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities
Liang Z. et al, (2021), Cell Communication and Signaling, 19
DUB esterase activity further decodes ubiquitin’s enigma
Kessler BM., (2021), Proceedings of the National Academy of Sciences, 118, e2026389118 - e2026389118
Drosophila Sex Peptide controls the assembly of lipid microcarriers in seminal fluid.
Wainwright SM. et al, (2021), Proceedings of the National Academy of Sciences of the United States of America, 118
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP
Feneberg E. et al, (2021), Brain Pathology